A novel PDX modeling strategy and its application in metabolomics study for malignant pleural mesothelioma

Abstract Background Malignant pleural mesothelioma (MPM) is a rare and aggressive carcinoma located in pleural cavity. Due to lack of effective diagnostic biomarkers and therapeutic targets in MPM, the prognosis is extremely poor. Because of difficulties in sample extraction, and the high rate of mi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zhongjian Chen, Chenxi Yang, Zhenying Guo, Siyu Song, Yun Gao, Ding Wang, Weimin Mao, Junping Liu
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/d667ec7deb8b4f9ebcd02aef60446ca3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d667ec7deb8b4f9ebcd02aef60446ca3
record_format dspace
spelling oai:doaj.org-article:d667ec7deb8b4f9ebcd02aef60446ca32021-11-21T12:30:24ZA novel PDX modeling strategy and its application in metabolomics study for malignant pleural mesothelioma10.1186/s12885-021-08980-51471-2407https://doaj.org/article/d667ec7deb8b4f9ebcd02aef60446ca32021-11-01T00:00:00Zhttps://doi.org/10.1186/s12885-021-08980-5https://doaj.org/toc/1471-2407Abstract Background Malignant pleural mesothelioma (MPM) is a rare and aggressive carcinoma located in pleural cavity. Due to lack of effective diagnostic biomarkers and therapeutic targets in MPM, the prognosis is extremely poor. Because of difficulties in sample extraction, and the high rate of misdiagnosis, MPM is rarely studied. Therefore, novel modeling methodology is crucially needed to facilitate MPM research. Methods A novel patient-derived xenograft (PDX) modeling strategy was designed, which included preliminary screening of patients with pleural thickening using computerized tomography (CT) scan, further reviewing history of disease and imaging by a senior sonographer as well as histopathological analysis by a senior pathologist, and PDX model construction using ultrasound-guided pleural biopsy from MPM patients. Gas chromatography-mass spectrometry-based metabolomics was further utilized for investigating circulating metabolic features of the PDX models. Univariate and multivariate analysis, and pathway analysis were performed to explore the differential metabolites, enriched metabolism pathways and potential metabolic targets. Results After screening using our strategy, 5 out of 116 patients were confirmed to be MPM, and their specimens were used for modeling. Two PDX models were established successfully. Metabolomics analysis revealed significant metabolic shifts in PDX models, such as dysregulations in amino acid metabolism, TCA cycle and glycolysis, and nucleotide metabolism. Conclusions To sum up, we suggested a novel modeling strategy that may facilitate specimen availability for MM research, and by applying metabolomics in this model, several metabolic features were identified, whereas future studies with large sample size are needed.Zhongjian ChenChenxi YangZhenying GuoSiyu SongYun GaoDing WangWeimin MaoJunping LiuBMCarticlePatient-derived xenograftMalignant pleural mesotheliomaGC-MSMetabolomicsUltrasound-guided biopsyNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENBMC Cancer, Vol 21, Iss 1, Pp 1-15 (2021)
institution DOAJ
collection DOAJ
language EN
topic Patient-derived xenograft
Malignant pleural mesothelioma
GC-MS
Metabolomics
Ultrasound-guided biopsy
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Patient-derived xenograft
Malignant pleural mesothelioma
GC-MS
Metabolomics
Ultrasound-guided biopsy
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Zhongjian Chen
Chenxi Yang
Zhenying Guo
Siyu Song
Yun Gao
Ding Wang
Weimin Mao
Junping Liu
A novel PDX modeling strategy and its application in metabolomics study for malignant pleural mesothelioma
description Abstract Background Malignant pleural mesothelioma (MPM) is a rare and aggressive carcinoma located in pleural cavity. Due to lack of effective diagnostic biomarkers and therapeutic targets in MPM, the prognosis is extremely poor. Because of difficulties in sample extraction, and the high rate of misdiagnosis, MPM is rarely studied. Therefore, novel modeling methodology is crucially needed to facilitate MPM research. Methods A novel patient-derived xenograft (PDX) modeling strategy was designed, which included preliminary screening of patients with pleural thickening using computerized tomography (CT) scan, further reviewing history of disease and imaging by a senior sonographer as well as histopathological analysis by a senior pathologist, and PDX model construction using ultrasound-guided pleural biopsy from MPM patients. Gas chromatography-mass spectrometry-based metabolomics was further utilized for investigating circulating metabolic features of the PDX models. Univariate and multivariate analysis, and pathway analysis were performed to explore the differential metabolites, enriched metabolism pathways and potential metabolic targets. Results After screening using our strategy, 5 out of 116 patients were confirmed to be MPM, and their specimens were used for modeling. Two PDX models were established successfully. Metabolomics analysis revealed significant metabolic shifts in PDX models, such as dysregulations in amino acid metabolism, TCA cycle and glycolysis, and nucleotide metabolism. Conclusions To sum up, we suggested a novel modeling strategy that may facilitate specimen availability for MM research, and by applying metabolomics in this model, several metabolic features were identified, whereas future studies with large sample size are needed.
format article
author Zhongjian Chen
Chenxi Yang
Zhenying Guo
Siyu Song
Yun Gao
Ding Wang
Weimin Mao
Junping Liu
author_facet Zhongjian Chen
Chenxi Yang
Zhenying Guo
Siyu Song
Yun Gao
Ding Wang
Weimin Mao
Junping Liu
author_sort Zhongjian Chen
title A novel PDX modeling strategy and its application in metabolomics study for malignant pleural mesothelioma
title_short A novel PDX modeling strategy and its application in metabolomics study for malignant pleural mesothelioma
title_full A novel PDX modeling strategy and its application in metabolomics study for malignant pleural mesothelioma
title_fullStr A novel PDX modeling strategy and its application in metabolomics study for malignant pleural mesothelioma
title_full_unstemmed A novel PDX modeling strategy and its application in metabolomics study for malignant pleural mesothelioma
title_sort novel pdx modeling strategy and its application in metabolomics study for malignant pleural mesothelioma
publisher BMC
publishDate 2021
url https://doaj.org/article/d667ec7deb8b4f9ebcd02aef60446ca3
work_keys_str_mv AT zhongjianchen anovelpdxmodelingstrategyanditsapplicationinmetabolomicsstudyformalignantpleuralmesothelioma
AT chenxiyang anovelpdxmodelingstrategyanditsapplicationinmetabolomicsstudyformalignantpleuralmesothelioma
AT zhenyingguo anovelpdxmodelingstrategyanditsapplicationinmetabolomicsstudyformalignantpleuralmesothelioma
AT siyusong anovelpdxmodelingstrategyanditsapplicationinmetabolomicsstudyformalignantpleuralmesothelioma
AT yungao anovelpdxmodelingstrategyanditsapplicationinmetabolomicsstudyformalignantpleuralmesothelioma
AT dingwang anovelpdxmodelingstrategyanditsapplicationinmetabolomicsstudyformalignantpleuralmesothelioma
AT weiminmao anovelpdxmodelingstrategyanditsapplicationinmetabolomicsstudyformalignantpleuralmesothelioma
AT junpingliu anovelpdxmodelingstrategyanditsapplicationinmetabolomicsstudyformalignantpleuralmesothelioma
AT zhongjianchen novelpdxmodelingstrategyanditsapplicationinmetabolomicsstudyformalignantpleuralmesothelioma
AT chenxiyang novelpdxmodelingstrategyanditsapplicationinmetabolomicsstudyformalignantpleuralmesothelioma
AT zhenyingguo novelpdxmodelingstrategyanditsapplicationinmetabolomicsstudyformalignantpleuralmesothelioma
AT siyusong novelpdxmodelingstrategyanditsapplicationinmetabolomicsstudyformalignantpleuralmesothelioma
AT yungao novelpdxmodelingstrategyanditsapplicationinmetabolomicsstudyformalignantpleuralmesothelioma
AT dingwang novelpdxmodelingstrategyanditsapplicationinmetabolomicsstudyformalignantpleuralmesothelioma
AT weiminmao novelpdxmodelingstrategyanditsapplicationinmetabolomicsstudyformalignantpleuralmesothelioma
AT junpingliu novelpdxmodelingstrategyanditsapplicationinmetabolomicsstudyformalignantpleuralmesothelioma
_version_ 1718418973432741888